In another hospital-based study among 1099 patients with laboratory-confirmed COVID-19, 168/757 (22.2%) had elevated AST, 158/741 (21.3%) had elevated ALT, 76/722 (10.5%) had elevated total bilirubin. The gene discussed is GPT; the disease is COVID-19.